Ifosfamide, methotrexate, and 5-fluorouracil: effective combination in resistant breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 26, Issue 1 Supplement, 1990, Pages

  Gad El Mawla, N ^a   Hamza, M R ^a   Zikri, Z K ^a   Elserafi, M ^a   El Khodari, A ^a   Khaled, H ^a   Gafaar, R ^a  

^a NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IFOSFAMIDE; MESNA; METHOTREXATE;

ADVANCED CANCER; ALOPECIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; PRIORITY JOURNAL; RECURRENT CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG RESISTANCE; FEMALE; FLUOROURACIL; HUMAN; IFOSFAMIDE; METHOTREXATE; MIDDLE AGE;

EID: 0025357055     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00685430     Document Type: Article

References (7)

1. Suppression der Transplantations-Reaktion durch eine neue Stickstoff-Lost-Verbindung, 3-(2-chloräthyl)-2-(-2-chloräthylamino)-tetrahydro-2H-1,3,2, Oxazaphosphorine-2-Oxid
2. Zytostatische Kombinationsbehandlung mit Vincristin und Ifosfamid
3. Erfahrungen mit der fraktionierten Ifosfamid Stosstherapie bei generalisierten malignen Tumoren
4. Hypothesis: discontinuous chemotherapy for advanced breast cancer
5. Ifosfamid bei malignen Tumoren
6. Ifosfamide in tumour therapy. An overview